PIONEER-3: Oral Semaglutide Shows Benefit in Type 2 Diabetes PIONEER-3: Oral Semaglutide Shows Benefit in Type 2 Diabetes

Higher doses of oral semaglutide reduce HbA1c better than sitagliptin in type 2 diabetes but has more gastrointestinal side effects. NDAs for the product have just been filed in the US.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news